Sage Rhino Capital’s Clover Health Investments CLOV Stock Holding History

Sage Rhino Capital’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-211,440	Closed	-$372K	–	391
2026 Q1	$372K	Sell	211,440 -179	-0.1%	-$388	0.07%	171
2025 Q4	$497K	Hold	211,619	–	–	0.09%	144
2025 Q3	$648K	Buy	211,619 +86	+0%	+$246	0.13%	123
2025 Q2	$590K	Sell	211,533 -107	-0.1%	-$352	0.12%	118
2025 Q1	$760K	Hold	211,640	–	–	0.18%	100
2024 Q4	$667K	Sell	211,640 -10	-0%	-$36	0.15%	109
2024 Q3	$597K	Sell	211,650 -49,850	-19%	-$114K	0.13%	122
2024 Q2	$322K	Hold	261,500	–	–	0.08%	162
2024 Q1	$208K	Hold	261,500	–	–	0.05%	205
2023 Q4	$249K	Hold	261,500	–	–	0.06%	178
2023 Q3	$282K	Hold	261,500	–	–	0.08%	157
2023 Q2	$235K	Hold	261,500	–	–	0.07%	182
2023 Q1	$221K	Hold	261,500	–	–	0.06%	190
2022 Q4	$243K	Hold	261,500	–	–	0.08%	179
2022 Q3	$445K	Hold	261,500	–	–	0.18%	99
2022 Q2	$560K	Hold	261,500	–	–	0.21%	88
2022 Q1	$928K	Hold	261,500	–	–	0.28%	63
2021 Q4	$973K	Sell	261,500 -12,500	-5%	-$76.7K	0.27%	65
2021 Q3	$2.02M	Buy	+274,000	New	+$2.34M	0.62%	30

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sage Rhino Capital's CLOV Position: Q2 2026 in Review

Sage Rhino Capital sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 211,440 shares — an estimated $372K sold.

Sage Rhino Capital first reported a position in CLOV in Q3 2021 and held it in 19 quarters. The position peaked at $2.02M in Q3 2021. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Sage Rhino Capital reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
Sage Rhino Capital sold 211,440 Clover Health Investments shares in Q2 2026, an estimated $372K.
Sage Rhino Capital first reported a position in Clover Health Investments in Q3 2021 and held it in 19 quarters.
Sage Rhino Capital's Clover Health Investments position peaked at $2.02M in Q3 2021.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.